BMGL baselmedical.com: Koefisien utang jangka dawa marang modal

BMGL (Basel Medical) - tandha merek perusahaan

Basel Medical Group aims to solidify its leadership in Asia through premium services and high physician salaries. The historical long-term debt-to-equity ratio demonstrates the progress of this strategy, with the latest parameter standing at 1.04. However, the implementation of ESG waste disposal standards and rising rental costs, coupled with labor shortages, create significant financial headwinds.

Basel Medical Group Limited (BMGL): Utang jangka dawa marang modal saka 26.02.2025 nganti 28.10.2026
Produk merek Basel Medical Group

The ratio determines the share of long-term liabilities exceeding one year within the company's equity structure. The dynamics of the long-term debt-to-equity ratio reflect the degree of financial leverage and the asset's debt sustainability. This metric allows for a risk-profile assessment by comparing borrowed funds against the core business value. For Basel Medical Group (BMGL), such investments support expansion within the diagnostics segment. This is critically important when expanding the client base amid growing demand for healthcare.

Pesaing Basel Medical Group

Rasio silihan jangka dawa marang modal HCA|Tenet (THC) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal Fresenius Medical (FMS)|SOLV: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal encompasshealth.com EHC|Universal Health Services Corp - Utang jangka dawa marang modal|DaVita HealthCare Partners (DVA) - Utang jangka dawa marang modal|RDNT - Rasio utang jangka dawa marang ekuitas|OPCH (Option Care Corp) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas SGRY|Rasio utang jangka dawa marang ekuitas premierinc.com|National Vision - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal PGNY (Progyny Inc)|ARDT - Utang jangka dawa marang ekuitas|SEM - Rasio utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Astrana Health, Inc. ASTH|MD - Rasio silihan jangka dawa marang modal|usph.com (USPH) - Utang jangka dawa marang modal|Pennant Group (PNTG) - Utang jangka dawa marang ekuitas|ORGO (Organogenesis Inc.) - Utang jangka dawa marang modal|Utang jangka dawa marang modal NUTX|AUNA (Auna SA) - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal SBC Medical Group Holdings Inc. (SBC)|EOLS: Utang jangka dawa marang modal|CHS - Kewajiban jangka dawa marang modal|SKIN - Utang jangka dawa marang ekuitas|MediWound Ltd. (MDWD) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas biote Corp. BTMD|JYNT (thejoint.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas DCGO|Rasio utang jangka dawa marang ekuitas P3 Health|Gain Therapeutics, Inc. - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal euda.com (EUDA)|CLGN - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal cuprina.com.sg CUPR|Utang jangka dawa marang modal CCM (Concord Medical)|AMS - Rasio tanggungan utang jangka dawa marang modal|MRM (MEDIROM Healthcare Group Inc) - Utang jangka dawa marang modal|Avalon GloboCare Corp. (ALBT) - Rasio utang jangka dawa marang ekuitas|DHAI (DIH Holding US, Inc.) - Utang jangka dawa marang modal|Utang jangka dawa marang modal XAGE|Utang jangka dawa marang ekuitas NewGenIvf (NIVF)|Utang jangka dawa marang ekuitas atipt.com ATIP|Rasio utang jangka dawa marang ekuitas CareMax Medical Group|Koefisien utang jangka dawa marang modal Kindly Health KDLY|Utang jangka dawa marang modal MODV|NVOS: Tanggungan utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas sunlinkhealth.com SSY|BACK (IMAC Holdings Inc) - Koefisien utang jangka dawa marang modal